RT Journal Article
SR Electronic
A1 Vinall, Maria
T1 JUPITER Subgroup Analysis Provides Convincing Evidence for Statin Therapy as Primary Prevention for CV Events in Older Individuals
JF MD Conference Express
YR 2009
FD SAGE Publications
VO 9
IS 4
SP 22
OP 23
DO 10.1177/155989770904015
UL http://mdc.sagepub.com/content/9/4/22.abstract
AB Results of a subgroup analysis from the JUPITER trial [NCT00239681] showed a significant reduction in major cardiovascular (CV) events in older, apparently healthy individuals who were treated with rosuvastatin compared with placebo.